Atlas Trials

Cognitive and Psychophysiological Effects of Delta-9-Tetrahydrocannabinol in Bipolar Disorder

Clinical trial NCT03206463 · TERMINATED

Trial details

NCT number
NCT03206463
Sponsor
Yale University
Status
TERMINATED
Phase
Phase 1
Study type
INTERVENTIONAL
Delta-9-TetrahydroncannabinolBipolar DisorderHealthy Controls
Start date
2017-08-01
Primary completion
2017-09-29
Enrollment
2

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.